Brookfield Corp’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,413
Closed -$455K 634
2023
Q1
$455K Buy
+8,413
New +$490K ﹤0.01% 581
2022
Q2
Sell
-49,745
Closed -$2.81M 637
2022
Q1
$2.81M Buy
+49,745
New +$2.6M 0.01% 350
2021
Q4
Sell
-238,732
Closed -$14.3M 667
2021
Q3
$14.3M Buy
238,732
+20,816
+10% +$1.31M 0.06% 105
2021
Q2
$13.5M Buy
217,916
+58,171
+36% +$3.88M 0.06% 106
2021
Q1
$10.4M Buy
159,745
+46,665
+41% +$3.04M 0.05% 108
2020
Q4
$7.44M Buy
+113,080
New +$6.65M 0.03% 121
2020
Q3
Sell
-43,519
Closed -$2.14M 398
2020
Q2
$2.14M Buy
+43,519
New +$2.35M 0.01% 209

Other funds holding EHC

Brookfield Corp's EHC Position: Q2 2023 in Review

Brookfield Corp sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 8,413 shares — an estimated $455K sold.

Brookfield Corp first reported a position in EHC in Q2 2020 and held it in 7 quarters. The position peaked at $14.3M in Q3 2021. 385 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

  • Brookfield Corp reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 8,413 Encompass Health shares in Q2 2023, an estimated $455K.
  • Brookfield Corp first reported a position in Encompass Health in Q2 2020 and held it in 7 quarters.
  • Brookfield Corp's Encompass Health position peaked at $14.3M in Q3 2021.
  • 385 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.